These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3469139)

  • 1. Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men.
    Evans BA; Dawson SG; McLean KA; Teece SA; Key PR; Bond RA; Macrae KD; Jesson WJ; Mortimer PP
    Genitourin Med; 1986 Dec; 62(6):384-9. PubMed ID: 3469139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual practices and condom usage in a cohort of homosexual men in relation to human immunodeficiency virus status.
    Tindall B; Swanson C; Donovan B; Cooper DA
    Med J Aust; 1989 Sep; 151(6):318-22. PubMed ID: 2593942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.
    Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH
    Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
    Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS.
    Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR
    Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.
    Melbye M; Biggar RJ; Ebbesen P; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA
    Br Med J (Clin Res Ed); 1984 Sep; 289(6445):573-5. PubMed ID: 6087972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
    Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
    Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year prospective study of HTLV-III/LAV infection in homosexual men.
    Weber JN; Wadsworth J; Rogers LA; Moshtael O; Scott K; McManus T; Berrie E; Jeffries DJ; Harris JR; Pinching AJ
    Lancet; 1986 May; 1(8491):1179-82. PubMed ID: 2871421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
    Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
    Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic.
    Evans BA; McCormack SM; Bond RA; MacRae KD; Thorp RW
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):473-5. PubMed ID: 3126866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphadenopathy and antibodies to HTLV-III in homosexual men. Clinical, laboratory and epidemiological features.
    Bienzle U; Guggenmoos-Holzmann I; Zwingenberger K; Thommsen R; Ritter K; Uy A; Bayer H; Schneider J; Hunsmann G; Coester CH
    Klin Wochenschr; 1985 Jul; 63(13):597-602. PubMed ID: 2993734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus (HIV) infection in the regular sexual partners of homosexual men with AIDS and persistent generalised lymphadenopathy.
    Weller IV; Carne CA; Sattentau Q; Smith A; Tedder RS; Clapham P; Dalgleish A; Weber J; Adler MW
    J Med Virol; 1987 May; 22(1):91-8. PubMed ID: 3108451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle.
    Collier AC; Barnes RC; Handsfield HH
    Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years.
    Frazer IH; Mackay IR; Crapper RM; Jones B; Gust ID; Sarngadharan MG; Campbell DC; Ungar B
    Q J Med; 1986 Oct; 61(234):921-33. PubMed ID: 3498182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study.
    Kingsley LA; Detels R; Kaslow R; Polk BF; Rinaldo CR; Chmiel J; Detre K; Kelsey SF; Odaka N; Ostrow D
    Lancet; 1987 Feb; 1(8529):345-9. PubMed ID: 2880160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibody to HTLV-III/LAV in a population attending a sexually transmitted diseases clinic.
    Rabkin CS; Thomas PA; Jaffe HW; Schultz S
    Sex Transm Dis; 1987; 14(1):48-51. PubMed ID: 3645806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy.
    Zanetti AR; Ferroni P; Colombo M; Cargnel A; Mari D; Zehender G; Rumi MG; Gringeri A; Ammassari M; Mannucci PM
    Ric Clin Lab; 1985; 15(4):357-64. PubMed ID: 3914699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.